{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q05586",
      "entity_text" : "GluN1",
      "entity_type" : "protein"
    },
    "participant_a" : [ {
      "in_model" : true,
      "identifier" : "uaz:UAZ00632",
      "entity_text" : "alpha-actinin",
      "entity_type" : "protein"
    }, {
      "in_model" : true,
      "identifier" : "uniprot:Q9UMF0",
      "entity_text" : "ICAM-5",
      "entity_type" : "protein"
    } ],
    "hypothesis_information" : false
  },
  "verbose_text" : "NMDA treatment decreased alpha-actinin binding to ICAM-5, and increased the binding to GluN1.",
  "reading_complete" : "2020-08-04T13:02:54Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T13:01:33Z",
  "trigger" : "increased",
  "evidence" : [ "alpha-actinin binding to ICAM-5, and increased the binding to GluN1" ],
  "pmc_id" : "4365481",
  "score" : 0
}